Pulzatórikus gonadotropin releasing hormon substitutio suprasellaris növekedésü craniopharyngeoma eltávolítását követöen.

Translated title of the contribution: Pulsatile gonadotropin-releasing hormone substitution following excision of a craniopharyngioma with suprasellar invasion

S. Koloszár, G. Bártfai, M. Sas

Research output: Contribution to journalArticle

Abstract

Craniopharyngeoma growing suprasellary attacks the medio-basal region of hypothalamus, that leads to the stopping of the production of gonadotropin releasing hormone. In connection with the case of a 15-year-old girl who had partial extirpation of craniopharyngeoma the authors write about the favourable endocrine effect of pulsatile gonadotropin releasing hormone treatment. Through giving gonadotropin releasing hormone every 90 minutes in 20 micrograms doses menstruation cycle and ovulation was performed. Beside surgical treatment hormonal substitution plays an important role in the treatment of additional endocrine symptoms.

Translated title of the contributionPulsatile gonadotropin-releasing hormone substitution following excision of a craniopharyngioma with suprasellar invasion
Original languageHungarian
Pages (from-to)139-141
Number of pages3
JournalOrvosi hetilap
Volume132
Issue number3
Publication statusPublished - Jan 20 1991

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Pulsatile gonadotropin-releasing hormone substitution following excision of a craniopharyngioma with suprasellar invasion'. Together they form a unique fingerprint.

  • Cite this